Product Article

Applied Filters:

facet content type:Product Article

facet product category:MILLIPLEX® Assays

facet topic area:Cancer Research

Showing 1-6 of 6 results

Autoantibody Multiplex Analysis | MILLIPLEX^® Assays

Multiplex analysis of autoantibodies, such as MILLIPLEX® multiplex assays, helps advance research by detecting multiple autoantibodies like cytokine autoantibodies, autoimmune autoantibodies, and cancer autoantibodies at once to give researchers a full picture of analyte concentrations.

Cell Signaling Multiplex Assays | MILLIPLEX^® Assays

Uncover how cells communicate with MILLIPLEX® cell signaling multiplex assays. Multiplexing with cell signaling phosphoprotein assays based on Luminex® xMAP® technology helps researchers measure phosphoproteins and total proteins within the same or different pathways from a single sample.

Multiplex Cancer Assays for Cancer Research| MILLIPLEX^® Assays

Cancer biomarker detection through MILLIPLEX® multiplex cancer assays can accelerate studies of tumorigenic processes helping advance cancer research.

Correlation of Angiogenesis Biomarkers with NSCLC | MILLIPLEX^® Assays

The angiogenesis pathway is complex with many targets to analyze. Simultaneous quantification of multiple markers, with the MILLIPLEX® Human Angiogenesis/Growth Factor Panel 1, saves valuable resources. See how this panel was used to correlate angiogenesis biomarkers with early metastatic progression

Multiplexing Cancer & Metastasis Signaling Pathways | MILLIPLEX^® Assays

Learn how multiplexing with MILLIPLEX® multiplex assays can help simplify cancer research by measuring multiple circulating biomarkers at once. Find multiplex panels to analyze JAK-STAT, mTOR, MAPK, SAPK, TGFβ signaling pathways, and more.

Multiplexed Evaluation of Soluble Immune-Checkpoint Molecules | MILLIPLEX^® Assays

Research evaluating immune checkpoints may help identify those likely to benefit from PD-1/PD-L1 immunotherapy and reveal new immunotherapy targets for future investigation. See how the MILLIPLEX® Human Immuno-Oncology Checkpoint Protein Panel 2 was used to multiplex immune checkpoint molecules for